Beck Howe - EVE Health Sales Professional
| EVE Stock | 0 0.00 0.00% |
Insider
Beck Howe is Sales Professional of EVE Health Group
| Address | 245 Churchill Avenue, Subiaco, WA, Australia, 6008 |
| Phone | 61 8 6465 5500 |
| Web | https://www.evehealthgroup.com.au |
EVE Health Management Efficiency
The company has return on total asset (ROA) of (0.2961) % which means that it has lost $0.2961 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7122) %, meaning that it generated substantial loss on money invested by shareholders. EVE Health's management efficiency ratios could be used to measure how well EVE Health manages its routine affairs as well as how well it operates its assets and liabilities. Total Current Liabilities is likely to drop to about 656 K in 2024. Liabilities And Stockholders Equity is likely to drop to about 2.4 M in 2024Similar Executives
| Showing other executives | INSIDER Age | ||
| Matt MBA | Qbe Insurance Group | N/A | |
| BA ACA | Qbe Insurance Group | N/A | |
| Craig Wright | Magellan Financial Group | N/A | |
| CFA CFA | Magellan Financial Group | N/A | |
| Domenico Giuliano | Magellan Financial Group | N/A | |
| Leo Quintana | Magellan Financial Group | N/A | |
| MAICD FCPA | Qbe Insurance Group | N/A | |
| Samuel BA | Qbe Insurance Group | 54 | |
| Kirsten Morton | Magellan Financial Group | N/A | |
| Gerald Stack | Magellan Financial Group | N/A | |
| David George | Magellan Financial Group | N/A | |
| Jason BSc | Qbe Insurance Group | 57 | |
| Ashley Dalziell | Qbe Insurance Group | N/A | |
| Inder BCom | Qbe Insurance Group | N/A | |
| Frank Casarotti | Magellan Financial Group | N/A | |
| Marcia Venegas | Magellan Financial Group | N/A | |
Management Performance
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.3 |
EVE Health Group Leadership Team
Elected by the shareholders, the EVE Health's board of directors comprises two types of representatives: EVE Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EVE. The board's role is to monitor EVE Health's management team and ensure that shareholders' interests are well served. EVE Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EVE Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BEc CPA, CFO Sec | ||
| Gregory Fry, MD CEO | ||
| Beck Howe, Sales Professional | ||
| Stephanie Yip, Marketing Director | ||
| Elizabeth Caiulo, Adm Professional | ||
| Benedict Rohr, Chief Officer | ||
| Robyn Ingersole, Chief Products |
EVE Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EVE Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.3 | ||||
| Profit Margin | (0.89) % | ||||
| Operating Margin | (0.75) % | ||||
| Current Valuation | 5.24 M | ||||
| Shares Outstanding | 5.27 B | ||||
| Shares Owned By Insiders | 51.24 % | ||||
| Price To Book | 4.31 X | ||||
| Price To Sales | 2.47 X | ||||
| Revenue | 2.13 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EVE Stock Analysis
When running EVE Health's price analysis, check to measure EVE Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EVE Health is operating at the current time. Most of EVE Health's value examination focuses on studying past and present price action to predict the probability of EVE Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EVE Health's price. Additionally, you may evaluate how the addition of EVE Health to your portfolios can decrease your overall portfolio volatility.